Aureus Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.5M | Buy |
|
|||||
|
2025
Q1 | $2.26M | Buy |
|
|||||
|
2024
Q4 | $286K | Buy |
|
|||||
|
2024
Q3 | $253K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $375K | Sell |
|
|||||
|
2023
Q4 | $419K | Hold |
|
|||||
|
2023
Q3 | $474K | Sell |
|
|||||
|
2023
Q2 | $2.64M | Sell |
|
|||||
|
2023
Q1 | $2.94M | Buy |
|
|||||
|
2022
Q4 | $3.04M | Buy |
|
|||||
|
2022
Q3 | $2.63M | Hold |
|
|||||
|
2022
Q2 | $2.84M | Buy |
|
|||||
|
2022
Q1 | $1.07M | Buy |
|
|||||
|
2021
Q4 | $908K | Sell |
|
|||||
|
2021
Q3 | $2.16M | Hold |
|
|||||
|
2021
Q2 | $2.44M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $311K | Sell |
|
|||||
|
2020
Q2 | $322K | Sell |
|
|||||
|
2020
Q1 | $338K | Sell |
|
|||||
|
2019
Q4 | $402K | Buy |
|
|||||
|
2019
Q3 | $308K | Hold |
|
|||||
|
2019
Q2 | $275K | Sell |
|
|||||
|
2019
Q1 | $407K | Sell |
|
|||||
|
2018
Q4 | $7.76M | Sell |
|
|||||
|
2018
Q3 | $13.6M | Buy |
|
|||||
|
2018
Q2 | $11.3M | Buy |
|
|||||
|
2018
Q1 | $12.6M | Sell |
|
|||||
|
2017
Q4 | $12.3M | Sell |
|
|||||
|
2017
Q3 | $12.9M | Buy |
|
|||||
|
2017
Q2 | $11.2M | Buy |
|
|||||
|
2017
Q1 | $10.4M | Buy |
|
|||||
|
2016
Q4 | $9.6M | Buy |
|
|||||
|
2016
Q3 | $200K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $213K | Sell |
|
|||||
|
2015
Q4 | $252K | Buy |
|
|||||
|
2015
Q3 | $207K | Sell |
|
|||||
|
2015
Q2 | $237K | Buy |
|
|||||
|
2015
Q1 | $230K | Buy |
|